RYTM logo

Rhythm Pharmaceuticals, Inc. (RYTM) Selling, general & administrative expenses

annual SGA:

$0.00-$117.53M(-100.00%)
December 31, 2024

Summary

  • As of today (September 13, 2025), RYTM annual SGA is $0.00, with the most recent change of -$117.53 million (-100.00%) on December 31, 2024.
  • During the last 3 years, RYTM annual SGA has fallen by -$68.49 million (-100.00%).
  • RYTM annual SGA is now -100.00% below its all-time high of $117.53 million, reached on December 31, 2023.

Performance

RYTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

quarterly SGA:

$0.00-$39.09M(-100.00%)
June 30, 2025

Summary

  • As of today (September 13, 2025), RYTM quarterly SGA is $0.00, with the most recent change of -$39.09 million (-100.00%) on June 30, 2025.
  • Over the past year, RYTM quarterly SGA has dropped by -$36.41 million (-100.00%).
  • RYTM quarterly SGA is now -100.00% below its all-time high of $39.09 million, reached on March 31, 2025.

Performance

RYTM quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

TTM SGA:

-$4.72B-$183.10M(-4.03%)
June 30, 2025

Summary

  • As of today (September 13, 2025), RYTM TTM SGA is -$4.72 billion, with the most recent change of -$183.10 million (-4.03%) on June 30, 2025.
  • Over the past year, RYTM TTM SGA has dropped by -$4.86 billion (-3634.45%).
  • RYTM TTM SGA is now -9222.20% below its all-time high of -$50.67 million.

Performance

RYTM TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

RYTM Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-3634.4%
3 y3 years-100.0%-100.0%-5840.9%
5 y5 years-100.0%-100.0%-10000.0%

RYTM Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-112.5%at low
5 y5-year-100.0%at low-100.0%at low-245.3%at low
alltimeall time-100.0%at low-100.0%at low-9222.2%at low

RYTM Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$74.46M(-32.8%)
Mar 2025
-
$39.09M(>+9900.0%)
$110.88M(+4.4%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$106.17M(-23.4%)
Sep 2024
-
$35.38M(-2.9%)
$138.55M(+3.7%)
Jun 2024
-
$36.41M(+5.9%)
$133.65M(+5.0%)
Mar 2024
-
$34.38M(+6.2%)
$127.28M(+8.3%)
Dec 2023
$117.53M(+27.7%)
$32.37M(+6.2%)
$117.53M(+5.4%)
Sep 2023
-
$30.48M(+1.4%)
$111.47M(+8.3%)
Jun 2023
-
$30.05M(+22.0%)
$102.94M(+8.1%)
Mar 2023
-
$24.63M(-6.4%)
$95.22M(+3.5%)
Dec 2022
$92.03M(+34.4%)
$26.32M(+20.0%)
$92.03M(+6.1%)
Sep 2022
-
$21.94M(-1.7%)
$86.71M(+5.4%)
Jun 2022
-
$22.33M(+4.1%)
$82.28M(+9.1%)
Mar 2022
-
$21.45M(+2.2%)
$75.42M(+10.1%)
Dec 2021
$68.49M(+48.5%)
$21.00M(+19.9%)
$68.49M(+13.0%)
Sep 2021
-
$17.51M(+13.2%)
$60.61M(+11.4%)
Jun 2021
-
$15.46M(+6.5%)
$54.39M(+13.7%)
Mar 2021
-
$14.52M(+10.7%)
$47.85M(+3.7%)
Dec 2020
$46.13M(+26.2%)
$13.12M(+16.2%)
$46.13M(+8.7%)
Sep 2020
-
$11.29M(+26.5%)
$42.42M(+1.8%)
Jun 2020
-
$8.92M(-30.3%)
$41.67M(+0.2%)
Mar 2020
-
$12.80M(+35.9%)
$41.59M(+13.8%)
Dec 2019
$36.55M
$9.41M(-10.6%)
$36.55M(+2.9%)
Sep 2019
-
$10.54M(+19.2%)
$35.52M(+6.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
$8.84M(+13.9%)
$33.53M(+7.7%)
Mar 2019
-
$7.76M(-7.5%)
$31.12M(+10.8%)
Dec 2018
$28.08M(+195.0%)
$8.39M(-1.8%)
$28.08M(+16.9%)
Sep 2018
-
$8.54M(+32.7%)
$24.02M(+35.0%)
Jun 2018
-
$6.44M(+36.5%)
$17.80M(+39.9%)
Mar 2018
-
$4.71M(+8.9%)
$12.72M(+33.6%)
Dec 2017
$9.52M(+50.8%)
$4.33M(+87.0%)
$9.52M(+83.5%)
Sep 2017
-
$2.31M(+70.6%)
$5.19M(+80.6%)
Jun 2017
-
$1.36M(-10.5%)
$2.87M(+9.3%)
Mar 2017
-
$1.52M(+36.2%)
$2.63M(-52.5%)
Dec 2016
$6.31M(+84.3%)
-
-
Jun 2016
-
$1.11M(-24.4%)
$5.53M(+25.2%)
Mar 2016
-
$1.47M(-27.3%)
$4.42M(+49.9%)
Dec 2015
$3.42M(+182.4%)
-
-
Dec 2015
-
$2.02M(+119.6%)
$2.95M(+176.7%)
Sep 2015
-
$922.00K(+544.8%)
$1.06M(-45.5%)
Dec 2014
$1.21M(-64.7%)
$143.00K(-53.4%)
$1.95M(+7.9%)
Sep 2014
-
$307.00K(-67.4%)
$1.81M(+20.4%)
Jun 2014
-
$941.00K(+67.4%)
$1.50M(-6.6%)
Mar 2014
-
$562.00K(-46.3%)
$1.61M(-8.2%)
Dec 2013
$3.43M(+39.6%)
-
-
Jun 2013
-
$1.05M(+48.3%)
$1.75M(+148.3%)
Mar 2013
-
$706.00K
$706.00K
Dec 2012
$2.46M
-
-

FAQ

  • What is Rhythm Pharmaceuticals, Inc. annual SGA?
  • What is the all time high annual SGA for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. annual SGA year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. quarterly SGA year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. TTM SGA?
  • What is the all time high TTM SGA for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. TTM SGA year-on-year change?

What is Rhythm Pharmaceuticals, Inc. annual SGA?

The current annual SGA of RYTM is $0.00

What is the all time high annual SGA for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high annual SGA is $117.53M

What is Rhythm Pharmaceuticals, Inc. annual SGA year-on-year change?

Over the past year, RYTM annual SGA has changed by -$117.53M (-100.00%)

What is Rhythm Pharmaceuticals, Inc. quarterly SGA?

The current quarterly SGA of RYTM is $0.00

What is the all time high quarterly SGA for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high quarterly SGA is $39.09M

What is Rhythm Pharmaceuticals, Inc. quarterly SGA year-on-year change?

Over the past year, RYTM quarterly SGA has changed by -$36.41M (-100.00%)

What is Rhythm Pharmaceuticals, Inc. TTM SGA?

The current TTM SGA of RYTM is -$4.72B

What is the all time high TTM SGA for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high TTM SGA is -$50.67M

What is Rhythm Pharmaceuticals, Inc. TTM SGA year-on-year change?

Over the past year, RYTM TTM SGA has changed by -$4.86B (-3634.45%)
On this page